Zealand Pharma A/S 2015 SR
The report outlines Zealand Pharma's CSR activities for 2015, focusing on employee well-being, R&D ethics, environmental sustainability, and business ethics. A key highlight was the launch of the 'From peptide to patient' growth strategy and achieving a 33% female representation on the Board of Directors. The company reported high employee satisfaction at 97% and maintained a strong focus on animal welfare and quality management systems. Additionally, Zealand established new departments for HR, Regulatory, and Quality Assurance to support its organizational growth.
Company: Zealand Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2015
Type: SR
Pages: 10
Back to company
Zealand Pharma A/S
Corporate Social Responsibility Report
The report outlines Zealand Pharma's CSR activities for 2015, focusing on employee well-being, R&D ethics, environmental sustainability, and business ethics. A key highlight was the launch of the 'From peptide to patient' growth strategy and achieving a 33% female representation on the Board of Directors. The company reported high employee satisfaction at 97% and maintained a strong focus on animal welfare and quality management systems. Additionally, Zealand established new departments for HR, Regulatory, and Quality Assurance to support its organizational growth.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees